276546
Cost-effectiveness of a community-based, diabetes prevention program targeting a low SES Mexico-origin population
Methods We segmented the sample available at follow-up (n=341) into BMI categories and calculated the portion of each group losing 2% and 5% body weight over nine months. We calculated costs on an intent-to-treat basis. We forecasted disease outcomes, quality-adjusted life years (QALYs) gained, and lifetime costs associated with attaining 2% and 5% weight loss goals. We projected outcomes out 10 and 20 years.
Results The sample was predominantly female (81%), born in Mexico (77%), low-income, and middle-aged; 17% were normal weight; 41% were obese. Overall, 34% of the sample experienced at least 2% weight loss and 13% achieved at least 5% weight loss over nine months. The intervention was cost-effective over a 20-year time horizon for all groups in both scenarios with costs per QALY gained of $60,787 (2%) and $62,236 (5%), respectively. It was most cost-effective for the morbidly obese under the 5% / 20-year horizon scenario at $46/QALY.
Discussion The intervention's 2% weight loss results compare favorably to other community-based weight loss interventions. We demonstrate that culturally-appropriate community weight loss interventions can be highly cost-effective, especially for the morbidly obese.
Chronic disease management and prevention
Planning of health education strategies, interventions, and programs
Social and behavioral sciences
Learning Objectives:
Describe key components of a successful, community-based weight loss/maintenance program.
Compare the cost-effectiveness of community-based diabetes prevention programs.
Keywords: Obesity, Latino Health
Qualified on the content I am responsible for because: I have carried out cost-effectiveness analyses of multiple diabetes prevention / self-management programs targeting Mexican/Mexican-American populations, on published thus far. My research focuses on disparities in health care access and chronic disease management in Mexican/Mexican-American populations.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.